Stockreport

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher [Yahoo! Finance]

Viracta Therapeutics, Inc.  (VIRX) 
PDF an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals' recent sale of its Priority Review Voucher (PRV) for $108 milli [Read more]